Tri-Cira Lo 28 0.215 mg

TRI-CIRA LO 28 0.215 MG tablets contain norgestimate, a progestin used for hormonal contraception. This oral medication is designed for women seeking reliable birth control options.

TRI-CIRA LO 28 0.215 MG tablets are primarily used for hormonal contraception. Norgestimate, the active ingredient, works by preventing ovulation and altering the cervical mucus to hinder sperm movement. This medication is often prescribed to women looking for an effective method to prevent pregnancy. It is important to consult a healthcare provider to determine if this contraceptive is suitable for individual needs.

Common effects of TRI-CIRA LO 28 0.215 MG tablets may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users might experience mild side effects like headaches, nausea, or breast tenderness. These effects vary among individuals and typically subside as the body adjusts to the medication.

TRI-CIRA LO 28 0.215 MG tablets should be handled with care, stored at room temperature, and kept out of reach of children. It is essential to follow the prescribed dosage and schedule to maintain effectiveness. Women with a history of blood clots, liver disease, or certain cancers should discuss these conditions with their healthcare provider before starting this medication.

TRI-CIRA LO 28 0.215 MG tablets may interact with other medications, including certain antibiotics, anticonvulsants, and HIV medications. Alcohol consumption should be moderated, as it can affect the efficacy of hormonal contraceptives. Always inform healthcare providers about all medications and supplements being taken to avoid potential interactions.